dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pujol-Rojo, Miquel |
dc.contributor.author | Miró, Josep M. |
dc.contributor.author | Shaw, Evelyn |
dc.contributor.author | Aguado, Jose Maria |
dc.contributor.author | San-Juan, Rafael |
dc.contributor.author | Puig Asensio, Mireia |
dc.contributor.author | Pigrau Serrallach, Carles |
dc.date.accessioned | 2022-06-07T12:25:10Z |
dc.date.available | 2022-06-07T12:25:10Z |
dc.date.issued | 2021-05-01 |
dc.identifier.citation | Pujol M, Miró JM, Shaw E, Aguado JM, San-Juan R, Puig-Asensio M, et al. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial. Clin Infect Dis. 2021 May 1;72(9):1517–25. |
dc.identifier.issn | 1537-6591 |
dc.identifier.uri | https://hdl.handle.net/11351/7632 |
dc.description | Bacterièmia; Daptomicina; Fosfomicina |
dc.description.sponsorship | This work was supported by the Spanish Ministry of Science, Innovation and Universities (PI12/01907); Spanish Network for Research in Infectious Diseases (RD16/0016/0005); Instituto de Salud Carlos III (ISCIII); and Spanish Ministry of Economy, Industry and Competitiveness. This work was also supported by the European Development Regional Fund “A way to achieve Europe,” Operational Programme Intelligent Growth 2014–2020; Spanish Clinical Research Network (SCReN), co-financed by the Plan Nacional de I+D and ISCIII, Subdirección General de Evaluación y Fomento de la Investigación (PT13/0002/0007); and the Grupo de Estudio de la Infección Relacionada con la Asistencia Sanitaria. J. M.-M. received a personal 80:20 research grant from the Institut d’Investigacions Biomèdiques Agust Pi i Sunyer, Barcelona, Spain, during 2017–2021. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Clinical Infectious Diseases;72(9) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antibacterians - Ús terapèutic |
dc.subject | Infeccions per estafilococs - Tractament |
dc.subject.mesh | Staphylococcal Infections |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Anti-Bacterial Agents |
dc.subject.mesh | Combined Modality Therapy |
dc.title | Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/cid/ciaa1081 |
dc.subject.decs | infecciones estafilocócicas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antibacterianos |
dc.subject.decs | tratamiento combinado |
dc.relation.publishversion | https://doi.org/10.1093/cid/ciaa1081 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pujol M, Shaw E] Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biomèdiques de Bellvitge, University of Barcelona, Barcelona, Spain. [Miró JM] Department of Infectious Diseases, Hospital Clinic, Institut d’Investigacions Biomèdiques Agust Pi i Sunyer, University of Barcelona, Barcelona, Spain. [Aguado JM, San-Juan R] Department of Infectious Diseases, Hospital Universitario 12 Octubre, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain. [Puig-Asensio M, Pigrau C] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 32725216 |
dc.identifier.wos | 000757528700062 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |